Prognostic factors in multiple myeloma: the M.D. Anderson experience.
Barlogie
B
B
Alexanian
R
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D005500:Follow-Up Studies; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy / Q000401:mortality*; D009363:Neoplasm Proteins / Q000032:analysis; D011379:Prognosis; D012334:RNA, Neoplasm / Q000032:analysis; D014481:United States / Q000453:epidemiology
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm